Medical Devices Europe

Europe Transcatheter Aortic Valve Replacement Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Europe Transcatheter Aortic Valve Replacement Market Industry Trends and Forecast to 2034: Segmented by (Valve, Approach, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Europe · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $1.39 Bn Placeholder estimate
Estimate 2025 $1.50 Bn 19.4% of the global market
Projected 2034 $2.97 Bn 98.2% Adds $1.47 Bn over 9 forecast years
CAGR 2025–2034 7.9% Faster than 54% of 180 Medical Devices markets here
Key players 5
  • Europe is 19.38% of the global market.
  • Among regions, the largest is North America at $3.85 Bn.
  • Fastest growing: Africa at 10.9% a year.
  • Europe ranks 3rd of 6 by size among regions.

Market size projection

Europe

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$1.47 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Transcatheter Aortic Valve Replacement Market market size by year, Europe
YearMarket sizeChange that yearSince 2025
2024 (estimate) $1.39 Bn — —
2025 (base) $1.50 Bn +$109.6 Mn —
2026 (forecast) $1.62 Bn +$118.3 Mn +7.9%
2027 (forecast) $1.74 Bn +$127.6 Mn +16.4%
2028 (forecast) $1.88 Bn +$137.7 Mn +25.6%
2029 (forecast) $2.03 Bn +$148.6 Mn +35.5%
2030 (forecast) $2.19 Bn +$160.3 Mn +46.3%
2031 (forecast) $2.36 Bn +$173.0 Mn +57.8%
2032 (forecast) $2.55 Bn +$186.6 Mn +70.3%
2033 (forecast) $2.75 Bn +$201.4 Mn +83.7%
2034 (forecast) $2.97 Bn +$217.3 Mn +98.2%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Europe Transcatheter Aortic Valve Replacement Market Analysis at a glance
Market size, 2025$1.50 Bn placeholder estimate
Forecast, 2034$2.97 Bn placeholder estimate
Growth (CAGR), 2025–20347.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsValve, approach and end user (see all)
Key playersEdwards Lifesciences, Medtronic, Boston Scientific Corporation, Abbott Laboratories, Meril Life Sciences (see all)
Regulator in EuropeEU MDRSource: European Commission, medical devices. Checked 14 Nov 2026.
Active clinical trials23 in EuropeSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Europe Transcatheter Aortic Valve Replacement Market Analysis Executive Summary

Transcatheter aortic valve replacement replaces a narrowed heart valve through a catheter instead of open-heart surgery.

Key segments of the transcatheter Aortic Valve Replacement market include valve (Balloon-Expandable, Self-Expanding and Mechanically Expanded) and approach (Transfemoral, Transapical and Other Access).

Bar chart: Europe Transcatheter Aortic Valve Replacement market size, 2024–2034, placeholder estimates. $1.39 Bn in 2024, $1.50 Bn in 2025 and $2.97 Bn in 2034, 7.9% CAGR.
Europe Transcatheter Aortic Valve Replacement market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Europe Transcatheter Aortic Valve Replacement Market Dynamics

Market Growth Drivers

Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the transcatheter Aortic Valve Replacement market.

Opportunity

Less invasive procedures, remote monitoring of implanted devices and rising access to cardiac care in emerging markets give the transcatheter Aortic Valve Replacement market room to grow.

Market Restraints

High device prices, the need for trained specialists, reimbursement pressure and product recalls hold back the transcatheter Aortic Valve Replacement market.

Competitive Landscape for Transcatheter Aortic Valve Replacement Market in Europe

The transcatheter Aortic Valve Replacement market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Transcatheter Aortic Valve Replacement Market in Europe

Transcatheter Aortic Valve Replacement in Europe: rules, payment and research

In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first.⁠[1] In the countries we cover here, medical devices are regulated by ANSM (France)⁠[2], BfArM (Germany)⁠[3], Ministry of Health (Italy)⁠[4], Roszdravnadzor (Russia)⁠[5], AEMPS (Spain)⁠[6], MHRA (UK)⁠[7], IGJ (Netherlands)⁠[8], FAMHP (Belgium)⁠[9], Swissmedic (Switzerland)⁠[10], Läkemedelsverket (Sweden)⁠[11], Danish Medicines Agency (Denmark)⁠[12], URPL (Poland)⁠[13] and TITCK (Turkey)⁠[14]. Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines.⁠[15] ClinicalTrials.gov lists 23 studies on Transcatheter Aortic Valve Replacement that are recruiting, active or about to start in Europe.⁠[16]

[1] European Commission, medical devices. Checked 14 Nov 2026.

[2] ANSM, French medicines agency. Checked 14 Nov 2026.

[3] Federal Institute for Drugs and Medical Devices (BfArM). Checked 14 Nov 2026.

[4] Italian Ministry of Health. Checked 14 Nov 2026.

[5] Roszdravnadzor. Checked 14 Nov 2026.

[6] Spanish Agency of Medicines and Medical Devices (AEMPS). Checked 14 Nov 2026.

[7] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.

[8] Health and Youth Care Inspectorate (IGJ). Checked 19 Nov 2026.

[9] Federal Agency for Medicines and Health Products (FAMHP). Checked 19 Nov 2026.

[10] Swissmedic. Checked 19 Nov 2026.

[11] Swedish Medical Products Agency (Läkemedelsverket). Checked 19 Nov 2026.

[12] Danish Medicines Agency. Checked 19 Nov 2026.

[13] Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL). Checked 19 Nov 2026.

[14] Turkish Medicines and Medical Devices Agency (TITCK). Checked 19 Nov 2026.

[15] European Commission, health technology assessment. Checked 14 Nov 2026.

[16] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how transcatheter Aortic Valve Replacement products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Europe.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Transcatheter Aortic Valve Replacement right now, from free public sources.

Clinical trials

23 active trials in UK, Germany, France, Italy, Spain, Netherlands, Belgium, Switzerland, Sweden, Denmark, Poland, Turkey and Russia

Recruiting, about to start, or running now. Counted across the 13 countries we report on in Europe.

Top trial sponsors (worldwide)

  1. Edwards Lifesciences 10 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Caranx Medical 4 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Anteris Technologies Ltd. 4 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Emblok, Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Medtronic 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Patients

Early deaths from long-term diseases, % (WHO)
CountryValueYear
Belgium8.72023
Denmark9.52023
France9.72023
Germany11.12023
Italy8.42023
Netherlands9.52023
Poland16.32023
Russia23.32023
Spain9.02023
Sweden7.62023
Switzerland7.12023
Turkey14.12023
UK10.92023
Compare every country on the Public Health Dashboard

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory. Fetched 20 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Transcatheter Aortic Valve Replacement in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Transcatheter Aortic Valve Replacement market in Europe?
Placeholder estimate: about $1.50 Bn in 2025, rising to about $2.97 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Transcatheter Aortic Valve Replacement market in Europe growing?
Placeholder estimate: about 7.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Transcatheter Aortic Valve Replacement market report cover?
The report splits the market by valve (Balloon-Expandable, Self-Expanding, Mechanically Expanded), approach (Transfemoral, Transapical, Other Access) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Transcatheter Aortic Valve Replacement market?
Key players include Edwards Lifesciences, Medtronic, Boston Scientific Corporation, Abbott Laboratories and Meril Life Sciences.
What is driving the Transcatheter Aortic Valve Replacement market?
Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the transcatheter Aortic Valve Replacement market.
Who regulates Transcatheter Aortic Valve Replacement in Europe?
In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first. Source: European Commission, medical devices. Checked 14 Nov 2026.
How is healthcare paid for in Europe?
Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines. Source: European Commission, health technology assessment. Checked 14 Nov 2026.
How many clinical trials on Transcatheter Aortic Valve Replacement are running in Europe?
23 studies are recruiting, active or about to start in Europe, counted across the 13 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.
How much research is published on Transcatheter Aortic Valve Replacement?
PubMed lists 6,809 papers on Transcatheter Aortic Valve Replacement added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Europe

See all

Related on cardiovascular

See the topic